Invention Grant
- Patent Title: 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors
-
Application No.: US15316401Application Date: 2014-06-04
-
Publication No.: US10087176B2Publication Date: 2018-10-02
- Inventor: Gabriele Amari , Elisabetta Armani , Mauro Riccaboni , Andrea Rizzi , Charles Baker-Glenn , Wesley Blackaby , Herve Van De Poel , Ben Whittaker
- Applicant: Chiesi Farmaceutici S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- International Application: PCT/EP2014/061604 WO 20140604
- International Announcement: WO2015/185130 WO 20151210
- Main IPC: C07D453/02
- IPC: C07D453/02
Abstract:
The invention relates to novel 3,5-dichloro,4-(3,4-(cyclo-) alkoxyphenyl)-2-carbonyloxy)ethyl)pyridine compounds which are inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
Public/Granted literature
- US20170152256A1 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS Public/Granted day:2017-06-01
Information query
